What is Adipotide ?
Adipotide, also known as FTPP or proapoptotic peptide, may potentially be able to eradicate fat cells by specifically targeting the blood supply of those cells. Interestingly, Adipotide is believed to be very selective since it has been hypothesized to differentiate the blood vessels found in fat cells from those found throughout the rest of the organism. Research conducted on monkeys has indicated that Adipotide may lead to weight reduction, increase insulin sensitivity, and mitigate some of the negative consequences of type 2 diabetes.
Adipotide Peptide and Fat Cells
To determine whether Adipotide FTPP might kill fat cells, it was produced and evaluated using research studies in 2011. According to investigations conducted on primates, Adipotide seemed to target apoptosis in rhesus monkeys’ white adipose tissue (fat) blood vessels. Fat cells were suggested by researchers to simply perish following a deprivation of blood supply. Rapid weight loss, quick reduction in body mass index (BMI), and reduced insulin resistance features were the overall hypothesized outcomes of this particular intervention. Interestingly, Adipotide and subsequent fat reduction were speculated to have improved weight and contributed to changes in the observed eating habits of the primates.
There is a possibility that a protein receptor known as prohibitin may be responsible for mediating the targeting of Adipotide to the blood arteries that supply fat cells. Prohibitin is a membrane protein found in cancer cells and blood arteries serving white fat. Perhaps it is only present in these two places. These findings have indicated that this protein may be associated with adiposity.
